Anticipate generic drug launch
Drug patents …
… from Kazakhstan to Kalamazoo
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Find generic entry opportunities
Proactively manage your pharmacy inventory
Manage your formulary budget
|Title:||Low dose budesonide formulations and uses thereof|
|Abstract:||A metered unit dose comprising 40 .mu.g or less of budesonide is disclosed, as well as formulations thereof, and the use thereof for the treatment of nasal conditions.|
|Inventor(s):||Nilsson; Hans (Lund, SE), Santesson; Gordon (Horby, SE)|
|Assignee:||Astra Aktiebolag (Sodertalje, SE)|
Patent Claim Types:|
see list of patent claims
Field: Not categorized
Back Citations: 4th percentile
Forward Citations: 1st percentile
|Patent Number||Expiration Date|
|6,291,445||September 18, 2013|
|Foriegn Application Priority Data|
|Foreign Country||Foreign Patent Number||Foreign Patent Date|
|Sweden||9604486||Dec 05, 1996|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.